| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3269780 | HPB | 2009 | 5 Pages |
Abstract
In view of our limited experience, we conclude that hypertrophy of the non-embolized liver (FRL) is not altered after FOLFIRI-based NC.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Otmane Nafidi, Delphine Désy, Richard Létourneau, Jean Côté, Marylène Plasse, Franck Vandenbroucke, André Roy, Michel Dagenais, Réal W. Lapointe,